Security Snapshot

KRANESHARES TRUST - MSCI EMG EX CH (KEMX) Institutional Ownership

CUSIP: 500767769

13F Institutional Holders and Ownership History from Q2 2019 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

24

Shares (Excl. Options)

1,105,340

Price

$40.55

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+269,608
Value change
+$11,018,091
Number of holders
24
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$50.23
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • KEMX - KRANESHARES TRUST - MSCI EMG EX CH is tracked under CUSIP 500767769.
  • 24 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 24 to 18 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $44,818,389 to $48,627,004.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 24 institutions filings for Q1 2026.

Open SEC evidence

Security key

500767769

Latest holder period

Q1 2026

13F holders

24

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 24 institutional investors reported holding 1,105,340 shares of KRANESHARES TRUST - MSCI EMG EX CH (KEMX).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 926,827 $48,627,004 +$4,174,848 $52.47 18
2026 Q1 1,105,340 $44,818,389 +$11,018,091 $40.55 24
2025 Q4 975,444 $36,168,858 +$55,205 $37.08 21
2025 Q3 974,257 $33,714,092 +$1,331,251 $34.61 21
2025 Q2 935,793 $30,178,892 -$10,249,918 $32.25 16
2025 Q1 1,271,050 $35,433,617 -$2,160,205 $27.88 16
2024 Q4 1,349,134 $37,389,124 +$2,153,914 $27.71 20
2024 Q3 1,266,284 $39,544,348 -$1,470,301 $31.21 19
2024 Q2 1,316,645 $39,553,119 +$5,989,967 $30.04 21
2024 Q1 1,121,080 $32,876,576 +$6,332,322 $29.33 26
2023 Q4 905,791 $25,825,793 +$4,847,889 $28.51 17
2023 Q3 737,896 $18,922,527 +$1,832,786 $25.64 13
2023 Q2 666,082 $17,724,300 -$118,275 $26.61 9
2023 Q1 675,342 $17,118,328 +$8,474,005 $25.35 11
2022 Q4 341,041 $8,228,441 +$1,684,703 $24.13 6
2022 Q3 284,677 $6,373,214 -$2,438,651 $22.39 9
2022 Q2 393,602 $9,593,000 -$7,259,862 $24.36 9
2022 Q1 676,484 $20,155,000 +$2,152,771 $29.80 11
2021 Q4 604,226 $18,812,858 +$65,085 $31.13 10
2021 Q3 601,345 $19,055,000 -$590,002 $31.68 7
2021 Q2 619,965 $20,101,000 -$3,955,110 $32.42 8
2021 Q1 741,950 $23,040,000 +$21,990,852 $31.05 8
2020 Q4 33,786 $997,000 -$159,881 $29.51 1
2020 Q3 39,204 $930,000 +$9,511 $23.72 1
2020 Q2 38,823 $849,000 -$54,457 $22.04 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .